Cargando…

Development and Validation of a Novel Prognostic Model for Lower-Grade Glioma Based on Enhancer RNA-Regulated Prognostic Genes

Enhancer RNAs (eRNAs) are present specifically in tumors, where they affect the expression of eRNA-regulated genes (ERGs). Owing to this characteristic, ERGs were hypothesized to improve prognosis of overall survival in heterogeneous low-grade and intermediate-grade gliomas. This study aimed to cons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Wei, Yan, Guangcan, Chen, Kegong, Han, Xinhao, Zhang, Wei, Sun, Lin, Zhang, Qi, Zhang, Yafeng, Li, Yan, Liu, Meina, Zhang, Qiuju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921558/ https://www.ncbi.nlm.nih.gov/pubmed/35299740 http://dx.doi.org/10.3389/fonc.2022.714338

Ejemplares similares

A Novel Prognostic Tool for Glioma Based on Enhancer RNA-Regulated Immune Genes
por: Tian, Wei, et al.
Publicado: (2022)

A Novel and Robust Prognostic Model for Hepatocellular Carcinoma Based on Enhancer RNAs-Regulated Genes
por: Zhang, Wei, et al.
Publicado: (2022)

Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
por: Deng, Xiangyang, et al.
Publicado: (2019)

Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma
por: Xu, Shenbin, et al.
Publicado: (2021)

Development and validation of a predictive model for depression risk in the U.S. adult population: Evidence from the 2007–2014 NHANES
por: Tian, Wei, et al.
Publicado: (2023)

Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade Glioma
por: Yin, Wen, et al.
Publicado: (2020)

Prognostic Value of an Autophagy-Related Five-Gene Signature for Lower-Grade Glioma Patients
por: Guo, Jin-Cheng, et al.
Publicado: (2021)

Integrated Analysis Reveals Prognostic Value and Immune Correlates of CD86 Expression in Lower Grade Glioma
por: Qiu, Huaide, et al.
Publicado: (2021)

Identifying α-KG-dependent prognostic signature for lower-grade glioma based on transcriptome profiles
por: Zhang, Tan, et al.
Publicado: (2022)

WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade Gliomas
por: Carstam, Louise, et al.
Publicado: (2022)

Development and Validation of a Radiosensitivity Prediction Model for Lower Grade Glioma Based on Spike-and-Slab Lasso
por: Du, Zixuan, et al.
Publicado: (2021)

Identification and Verification on Prognostic Index of Lower-Grade Glioma Immune-Related LncRNAs
por: Wen, Jing, et al.
Publicado: (2020)

OSlgg: An Online Prognostic Biomarker Analysis Tool for Low-Grade Glioma
por: An, Yang, et al.
Publicado: (2020)

The Prognostic Value of the Prognostic Nutritional Index in Operable High-Grade Glioma Patients and the Establishment of a Nomogram
por: He, Qian, et al.
Publicado: (2022)

Integrin Alpha-2 as a Potential Prognostic and Predictive Biomarker for Patients With Lower-Grade Glioma
por: Lin, Li, et al.
Publicado: (2021)

Integrative Analysis of a Novel Eleven-Small Nucleolar RNA Prognostic Signature in Patients With Lower Grade Glioma
por: Deng, Teng, et al.
Publicado: (2021)

Integrated analysis of genome-wide DNA methylation and cancer-associated fibroblasts identified prognostic biomarkers and immune checkpoint blockade in lower grade gliomas
por: Dong, Jiawei, et al.
Publicado: (2023)

Prognostic and Predictive Value of Immune-Related Gene Pair Signature in Primary Lower-Grade Glioma Patients
por: Lei, Kunjian, et al.
Publicado: (2021)

Behavior-Oriented Nomogram for the Stratification of Lower-Grade Gliomas to Improve Individualized Treatment
por: Wei, Ruo-Lun, et al.
Publicado: (2020)

Engrailed 1 overexpression as a potential prognostic marker in Lower Grade Glioma
por: Zhu, Jin, et al.
Publicado: (2019)

Identification of an epigenetic prognostic signature for patients with lower‐grade gliomas
por: Yu, Hai, et al.
Publicado: (2021)

Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker FAM111A in Diffuse Lower-Grade Glioma
por: Ji, Xiaoshuai, et al.
Publicado: (2020)

Development and validation of cuproptosis-associated prognostic signatures in WHO 2/3 glioma
por: Ye, Zhang, et al.
Publicado: (2022)

Circulating miRNAs as Diagnostic and Prognostic Biomarkers in High-Grade Gliomas
por: Wu, Jianing, et al.
Publicado: (2022)

Development and Validation of an Mesenchymal-Related Long Non-Coding RNA Prognostic Model in Glioma
por: Huang, Kebing, et al.
Publicado: (2021)

Preclinical modeling of lower-grade gliomas
por: Tang, Lilly W., et al.
Publicado: (2023)

Validation of the functions and prognostic values of synapse-associated proteins in lower-grade glioma
por: Lin, Han, et al.
Publicado: (2021)

FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma
por: Yan, Tengfeng, et al.
Publicado: (2022)

Prognostic significance of age related genes in patients with lower grade glioma
por: Wang, Haiwei, et al.
Publicado: (2020)

Radiomics Features Predict CIC Mutation Status in Lower Grade Glioma
por: Zhang, Luyuan, et al.
Publicado: (2020)

Identification and Validation of a Prognostic Immune-Related Alternative Splicing Events Signature for Glioma
por: Wang, Minjie, et al.
Publicado: (2021)

Exploring the relationship between abnormally high expression of NUP205 and the clinicopathological characteristics, immune microenvironment, and prognostic value of lower-grade glioma
por: Liang, Wenjia, et al.
Publicado: (2023)

Construction of a disease‐specific lncRNA‐miRNA‐mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma
por: Zhang, Qi, et al.
Publicado: (2020)

A Bioinformatic Analysis: The Overexpression and Prognostic Potential of GPX7 in Lower-Grade Glioma
por: Zhao, Qianqian, et al.
Publicado: (2022)

NCAPG2 Is a Novel Prognostic Biomarker and Promotes Cancer Stem Cell Maintenance in Low-Grade Glioma
por: Ren, Wenjun, et al.
Publicado: (2022)

Prognostic Value of Immune-Related lncRNA SBF2-AS1 in Diffuse Lower-Grade Glioma
por: Zhang, Qiang, et al.
Publicado: (2021)

Malignant Tumor Purity Reveals the Driven and Prognostic Role of CD3E in Low-Grade Glioma Microenvironment
por: Lu, Xiuqin, et al.
Publicado: (2021)

Genome‐wide methylomic analyses identify prognostic epigenetic signature in lower grade glioma
por: Guo, Wenna, et al.
Publicado: (2021)

Microvascular characteristics of lower-grade diffuse gliomas: investigating vessel size imaging for differentiating grades and subtypes
por: Guo, Hong, et al.
Publicado: (2018)

PD-L2 Serves as a Potential Prognostic Biomarker That Correlates With Immune Infiltration and May Predict Therapeutic Sensitivity in Lower-Grade Gliomas
por: Xie, Qijun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n1b0nv43ulqfr89kij5iot2td5